Pharmacological stimulation for IVF in Thailand typically costs from AUD $4,259 / ฿A144,798 to AUD $7,098 / ฿A241,330. The final price depends on the specific hormone protocol, dosage requirements, and whether medications are bundled into a larger IVF package. In Australia, this procedure costs around AUD $5,678 / ฿A193,064 on average, meaning patients can save approximately 25% by travelling to medical hubs like Bangkok.
Bookimed Expert Insight: Choosing a clinic with an on-site high-tech lab can offer better value for complex cases. For example, Bumrungrad International Hospital is a JCI-accredited facility that treats over one million patients annually. Specialist doctors like Dr. Teraporn Vutyavanich, who is ESHRE-certified, often customise stimulation protocols for patients with poor ovarian reserve. Some clinics include a set amount of medication in IVF packages, which can simplify budgeting for Australians. While Bangkok is the primary hub, its top-tier hospitals are frequently ranked among the most technologically advanced globally.
| Thailand | Turkey | South Korea | |
| Pharmacological stimulation for IVF | from AUD $4,259 / ฿A144,798 | from AUD $1,207 / ฿A41,026 | from AUD $2,981 / ฿A101,359 |
Dr Poonkiat Punyamitr is a certified Specialist in Assisted Reproductive Technology who leads the team at Prime Fertility Center.
Dr. Chaisuk Jiwatanaporn is an obstetrician-gynaecologist (OB-GYN) with a subspecialty in reproductive medicine. Dr. Jiwatanaporn earned an MD from the Faculty of Medicine, Chulalongkorn University in 1999. Dr. Jiwatanaporn holds the Thai Board in Obstetrics and Gynaecology from the Medical Council of Thailand, completed at Chonburi Hospital. Dr. Jiwatanaporn completed a fellowship in reproductive medicine at Chulalongkorn University in 2009. Practice areas include general obstetrics and gynaecology, reproductive endocrinology and infertility, and gynaecologic endoscopy.
Continuing education includes ESHRE workshops and annual meetings in Lisbon (2016), Geneva (2017), Barcelona (2018), and Vienna (2019). Additional meetings include ASPIRE 2019 in Hong Kong, TSRM 2019 in Pattaya, and COGI 2019 in Paris. Professional memberships include the Medical Council of Thailand, RTCOG, TSRM, TSGR, and ESHRE.
Dr. Wasin Naknam is an obstetrician-gynecologist and reproductive medicine specialist. He earned his MD from Chiang Mai University, Thailand, in 2012. He received Thai Board certification in Obstetrics and Gynecology in 2016. He completed the Thai Board of Infertility and Assisted Reproductive Technology in 2018. He obtained a master’s in Biotechnology of Assisted Human Reproduction and Embryology from the University of Valencia, Spain, in 2021.
Clinical focus: IUI and IVF/ICSI (long, antagonist, and double stimulation protocols). Customized ovarian stimulation for poor ovarian reserve and PCOS. Targeted care for repeated embryo transfer failure. PGT-A, PGT-M, and PGT-SR. Laparoscopy and hysteroscopy for infertility.
Professional activities: ESHRE workshops and annual meetings in 2017 (Geneva), 2018 (Barcelona), and 2019 (Vienna). TSRM seminar and conference in Pattaya in 2019. Poster presentation at ESHRE 2020 (virtual). Memberships: ASPIRE, ESHRE, ASRM, and TSRM.
Prof. Dr. Teraporn Vutyavanich specializes in Obstetrics & Gynecology, Assisted Reproductive Medicine, and Endocrinology. He is known as the father of assisted reproductive medicine in Thailand and the country’s first specialist in this field. He has authored over 100 publications. He chaired the Thai Society for Reproductive Medicine from 2005 to 2010 and from 2015 to the present.
He is a Professor at Chiang Mai University. He also serves as Director of the Reproductive Center at Chiang Mai University and Medical Director of the Chiang Mai IVF Polyclinic. He holds an MD (Honours) from Mahidol University. He is board-certified by the Thai Board of Obstetrics & Gynaecology and the Thai Subspecialty Board of Reproductive Medicine. He earned an M.Sc. in Medical Sciences from the University of Nottingham and an M.Sc. in research design from McMaster University. He completed fellowships in reproductive endocrinology at New York Hospital–Cornell and the Mayo Clinic under the Ananda Mahidol Scholarship. He is an ESHRE-certified senior embryologist.
The risk of Ovarian Hyperstimulation Syndrome (OHSS) in Thailand is consistently low. Moderate cases affect approximately 11% of patients. Severe cases occur in less than 1% of cycles. These rates align with global safety standards at JCI-accredited facilities like Bumrungrad International Hospital.
Bookimed Expert Insight: Thai specialists like Dr Wasin Naknam often use Spanish-trained embryology techniques and double stimulation protocols. These protocols allow clinics to manage high responders more precisely than standard Australian cycles. This specialised oversight helps keep severe complications extremely rare despite high patient volumes.
Patient Consensus: Patients recommend asking clinics about GnRH antagonist protocols and tracking estradiol levels frequently. These shared experiences highlight how proactive monitoring during stimulation provides peace of mind during IVF in Thailand.
Patients typically stay in Thailand for 10 to 14 days for the full stimulation phase. This timeframe covers daily hormone injections and regular monitoring at clinics like Bumrungrad International Hospital. It concludes with the final trigger shot and egg retrieval.
Bookimed Expert Insight: Thai specialists like Dr Wasin Naknam offer tailored approaches, including double stimulation and specific protocols for PCOS. Patients can often reduce their time abroad by using telemedicine for initial consultations. Clinics such as Sikarin Hospital frequently manage cases for Australian patients. This makes coordination with home-based doctors much smoother.
Patient Consensus: Visitors frequently mention that Thai fertility clinics provide a seamless experience for those travelling from Australia. Thorough monitoring and clear communication from English-speaking staff make the intensive two-week stimulation period feel organised.
Monitoring during IVF stimulation in Thailand requires clinic visits every 2 to 3 days. Most patients undergo 3 to 5 appointments over a 10-day window. These sessions include transvaginal ultrasounds and blood hormone tests. Board-certified specialists at JCI-accredited Bangkok facilities use this data to adjust medication dosages.
Bookimed Expert Insight: Data from hubs like Bumrungrad International Hospital shows they manage over 500,000 international cases annually. Their high volume means labs stay open 7 days a week. As a result, late-stage daily monitoring never pauses for weekends or local public holidays.
Patient Consensus: Clinics in Thailand drive the schedule based on follicle growth. It is not based on a fixed calendar. Expect visits to become near-daily just before the trigger shot. Staying close to the clinic makes the frequent morning scans and blood tests easier.
Patients can start IVF stimulation at home before travelling to Thailand for egg retrieval. This split-cycle approach involves completing the first 5 to 7 days of injections under local supervision. This reduces the stay in Bangkok to roughly 10 to 14 days.
Bookimed Expert Insight: Coordination is vital because some Thai centres require their own baseline scans before approval. JCI-accredited facilities like Bumrungrad International Hospital serve thousands of international patients. These hospitals often have established systems for remote starts. Checking if a specialist like Dr Wasin Naknam accepts your specific protocol early prevents costly cycle cancellations.
Patient Consensus: Successful patients suggest arriving in Thailand early to avoid missing critical follicle monitoring. Packing prescriptions and doctor letters helps when declaring medications at Thai customs.
Hormone injections for IVF stimulation in Thailand typically cause mild, manageable side effects. Most patients experience abdominal bloating, mood swings, fatigue, and sensitivity at the injection site. These reactions are biological responses to follicle-stimulating hormones. Specialists at JCI-accredited Bangkok hospitals monitor patients closely for safety.
Bookimed Expert Insight: Thai clinics like Sikarin Hospital frequently treat Australians and use tailored protocols to lower risks. Data shows that specialists such as Dr Wasin Naknam offer double stimulation or antagonist protocols. These customised approaches are vital for managing the side effects associated with polycystic ovary syndrome (PCOS).
Patient Consensus: Patients in Thailand report that bloating and tiredness build up gradually over several days. Rotating injection sites helps reduce soreness. The sense of pelvic pressure usually peaks just before egg retrieval.
Thai IVF clinics use internationally recognised fertility medications. Specialists prescribe Gonal-f, Puregon, or Menopur to stimulate follicle growth. These protocols often include GnRH antagonists like Cetrotide. Trigger shots such as Ovidrel or Pregnyl start final egg maturation before retrieval.
Bookimed Expert Insight: Thai specialists like Dr Wasin Naknam at Deep Health Care often use double stimulation protocols. These are common for patients with poor ovarian reserves. While global brands are standard, stocking varies between clinics. High-volume centres like Bumrungrad International Hospital maintain consistent access to specific recombinant FSH brands.
Patient Consensus: Patients in Thailand find that clinics can usually match home-country brands. They recommend confirming specific brand availability early for a smooth medication transition.
The pharmacological stimulation phase in Thailand typically lasts 8 to 14 days. Most patients average 10 to 12 days of daily injections. Specialists at JCI-accredited facilities like Bumrungrad International Hospital monitor follicle growth. They use frequent ultrasounds and blood tests to track progress.
Bookimed Expert Insight: While stimulation in Thailand costs from $3,000 to $5,000, some fly in on Day 5 to finish monitoring. Starting locally at Sikarin Hospital provides consistent specialist oversight throughout the entire 14-day window.
Patient Consensus: Stimulation in Thailand usually lasts around two weeks. Monitoring determines the exact retrieval date. Patients suggest keeping travel schedules flexible to accommodate slight timing shifts.